To interrogate the effect of CREM knockdown on non-malignant and malignant cells, we used three cell lines: Human embryonic kidney cell line HEK 293, human prostate carcinoma cell line PC-3, and human melanoma WM164 cell line. The gene discussed is CREM; the disease is prostate carcinoma.